Home » Topics » Disease categories and therapies » Urology

Urology
RSS

ET antagonists may have therapeutic role in diabetic erectile dysfunction

June 6, 2001

Patent covers Ferring's new vasopressin V2 receptor agonists and uses

June 5, 2001

Palatin's PT-141 ED treatment well tolerated in phase I trial

June 5, 2001

AUA news: AII antagonist, ACE inhibitor protect against postischemic acute renal failure

June 5, 2001

Superior side effect profile of tolterodine vs. oxybutynin in overactive bladder

June 1, 2001

Potent new PDE5 inhibitors designed by Pfizer group

May 30, 2001

Takeda's Ixense approved in Europe for ED

May 30, 2001

Pfizer describes potent new phosphodiesterase inhibitors and potential therapeutic uses

May 29, 2001

Merck presents amine derivatives with PDE5-inhibitory effects

May 21, 2001

Preparation and therapeutic uses of new alpha1A-adrenoceptor antagonists disclosed by Synaptic

May 18, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...